Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain

Journal of Virology

Volumn 80, Issue 8, 2006, Pages 3844-3852

  Lee, Jae Hyung ^a   Murphy, Scan C ^a,d   Belshan, Michael ^a,e   Sparks, Wendy O ^a   Wannemuehler, Yvonne ^a   Liu, Sijun ^a   Hope, Thomas J ^b   Dobbs, Drena ^a   Carpenter, Susan ^a,c  

^a IOWA STATE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; GENOMIC RNA; GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; NONESSENTIAL AMINO ACID; REV PROTEIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CISTRON; EQUINE INFECTIOUS ANEMIA VIRUS; EXON; GENE DELETION; GENE MAPPING; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; RNA BINDING; RNA EXTRACTION; SEQUENCE ANALYSIS;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BINDING SITES; GENE PRODUCTS, REV; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; RNA, VIRAL;

EQUINE INFECTIOUS ANEMIA VIRUS;

EID: 33645777243     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.8.3844-3852.2006     Document Type: Article

References (48)

1. Akiyama, Y., T. Hosoya, A. M. Poole, and Y. Hotta. 1996. The gem-motif: a novel DNA-binding motif conserved in Drosophila and mammals. Proc. Natl. Acad. Sci. USA 93:14912-14916.
2. Alexandersen, S., and S. Carpenter. 1991. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J. Virol. 65:4255-4262.
3. Ali, S. A., and A. Steinkasserer. 1995. PCR-ligation-PCR mutagenesis: a protocol for creating gene fusions and mutations. BioTechniques 18:746-750.
4. Baccam, P., R. J. Thompson, Y. Li, W. O. Sparks, M. Belshan, K. S. Dorman, Y. Wannemuehler, J. L. Oaks, J. L. Cornette, and S. Carpenter. 2003. Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype. J. Virol. 77:12122-12131.
5. Beisel, C. E., J. F. Edwards, L. L. Dunn, and N. R. Rice. 1993. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J. Virol. 67:832-842.
6. Belshan, M., P. Baccam, J. L. Oaks, B. A. Sponseller, S. C. Murphy, J. Cornette, and S. Carpenter. 2001. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Virology 279:185-200.
7. Belshan, M., M. E. Harris, A. E. Shoemaker, T. J. Hope, and S. Carpenter. 1998. Biological characterization of Rev variation in equine infectious anemia virus. J. Virol. 72:4421-4426.
8. Belshan, M., G. S. Park, P. Bilodeau, C. M. Stoltzfus, and S. Carpenter. 2000. Binding of equine infectious anemia virus Rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs. Mol. Cell. Biol. 20:3550-3557.
9. Burd, C. G., and G. Dreyfuss. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615-621.
10. Carpenter, S., S. Alexandersen, M. J. Long, S. Perryman, and B. Chesebro. 1991. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J. Virol. 65:1605-1610.
11. Carpenter, S., and B. Chesebro. 1989. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J. Virol. 63:2492-2496.
12. Carroll, R., and D. Derse. 1993. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon. J. Virol. 67:1433-1440.
13. Chou, H.-C., T.-Y. Hsieh, G.-T. Sheu, and M. M. C. Lai. 1998. Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J. Virol. 72:3684-3690.
14. Chung, H.-K., and D. Derse. 2001. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA. J. Biol. Chem. 276:18960-18967.
15. Cook, K., G. Sue, J. Fisk, J. Hauber, N. Usman, T. J. Daly, and J. R. Rusche. 1991. Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 19:1577-1583.
16. Cuff, J. A., M. E. Clamp, A. S. Siddiqui, M. Finlay, and G. J. Barton. 1998. JPred: a consensus secondary structure prediction server. Bioinformatics 14:892-893.
17. Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375-394.
18. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattal, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
19. Fridell, R. A., H. P. Bogerd, and B. R. Cullen. 1996. Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc. Natl. Acad. Sci. USA 93:4421-4424.
20. Fridell, R. A., K. M. Partin, S. Carpenter, and B. R. Cullen. 1993. Identification cation of the activation domain of equine infectious anemia virus Rev. J. Virol. 67:7317-7323.
21. Gontarek, R. R., and D. Derse. 1996. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol. Cell. Biol. 16:2325-2331.
22. Gorlich, D., and I. W. Mattaj. 1996. Nucleocytoplasmic transport. Science 271:1513-1518.
23. Harris, M. E., R. R. Gontarek, D. Derse, and T. J. Hope. 1998. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein. Mol. Cell. Biol. 18:3889-3899.
24. Hope, T. J., D. McDonald, X. Huang, J. Low, and T. G. Parslow. 1990. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus. J. Virol. 64:5360-5366.
25. Izaurralde, E., and S. Adam. 1998. Transport of macromolecules between the nucleus and the cytoplasm. RNA 4:351-364.
26. Jones, D. T. 1999. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292:195-202.
27. Kawakami, T., L. Sherman, J. Dahlbert, A. Gazit, A. Yaniv, S. R. Tronick, and S. A. Aaronson. 1987. Nucleotide sequence analysis of equine infectious anemia proviral DNA. Virology 158:300-312.
28. Kloczkowski, A., K. L. Ting, R. L. Jernigan, and J. Garnier. 2002. Combining the GOR V algorithm with evolutionary information for protein secondary structure prediction from amino acid sequence. Proteins 49:154-166.
29. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
30. Leroux, C., C. J. Issel, and R. C. Montelaro. 1997. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 71:9627-9639.
31. Liao, H.-J., C. C. Baker, G. L. Princier, and D. Derse. 2004. Cis-acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing. Virology 323:131-140.
32. Malim, M. H., S. Böhnlein, J. Hauber, and B. R. Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 58:205-214.
33. Mancuso, V. A., T. J. Hope, L. Zhu, D. Derse, T. Phillips, and T. G. Parslow. 1994. Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. J. Virol. 68:1998-2001.
34. Martarano, L., R. Stephens, N. Rice, and D. Derse. 1994. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J. Virol. 68:3102-3111.
35. Meyer, B. E., J. L. Meinkoth, and M. H. Malim. 1996. Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J. Virol. 70:2350-2359.
36. Nakielny, S., and G. Dreyfuss. 1999. Transport of proteins and RNAs in and out of the nucleus. Cell 99:677-690.
37. Olsen, H., A. Cochrane, P. Dillon, C. Nalin, and C. Rosen. 1990. Interaction of the human immunodeficiency virus type 1 rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1357-1364.
38. Otero, G. C., M. E. Harris, J. E. Donello, and T. J. Hope. 1998. Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus Rev function but not the function of the hepatitis B virus postranscriptional regulatory element. J. Virol. 72:7593-7597.
39. Ouali, M., and R. D. King. 2000. Cascaded multiple classifiers for secondary structure prediction. Protein Sci. 9:1162-1176.
40. Perkins, A., A. W. Cochrane, S. M. Ruben, and C. A. Rosen. 1989. Structural and functional characterization of the human immunodeficiency virus rev protein. J. Acquir. Immune Defic. Syndr. 2:256-263.
41. Pollard, V. W. 1998. The HIV-1 Rev protein. Annu. Rev. Microbiol. 52:491-532.
42. Rost, B., and C. Sander. 1993. Secondary structure prediction of all-helical proteins in two states. Protein Eng. 6:831-836.
43. Ryder, S. P., L. A. Frater, D. L. Abramovitz, E. B. Goodwin, and J. R. Williamson. 2004. RNA target specificity of the STAR/GSG domain posttranscriptional regulatory protein GLD-1. Nat. Struct. Mol. Biol. 11:20-28.
44. Stegh, A. H., O. Schickling, A. Ehret, C. Scaffidi, C. Peterhansel, T. G. Hofmann, I. Grummt, P. H. Krammer, and M. E. Peter. 1998. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J. 17:5974-5986.
45. Weiss, M. A., and N. Narayana. 1998. RNA recognition by arginine-rich peptide motifs. Biopolymers 48:167-180.
46. Whittaker, G., and A. Helenius. 1998. Nuclear import and export of viruses and virus genomes. Virology 246:1-23.
47. Zapp, M. T. Hope, T. Parslow, and M. Green. 1988. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus rev protein: a dual function for an arginine-rich motif. Proc. Natl. Acad. Sci. USA 88:7734-7738.
48. Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342:714-716.